『WolverHeme Happy Hour』のカバーアート

WolverHeme Happy Hour

WolverHeme Happy Hour

著者: Bernard Marini Anthony Perissinotti et al.
無料で聴く

概要

Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.Bernard Marini, Anthony Perissinotti, et al. 衛生・健康的な生活 身体的病い・疾患
エピソード
  • An Exercise in Uncertainty with Jonathan Gluck
    2026/02/10

    Anthony and Bernie are joined by special guest Jonathan Gluck, award-winning journalist and author of "An Exercise in Uncertainty: A Memoir of Illness and Hope" for a powerful conversation about living through uncertainty.


    Drawing on his decades-long journey with multiple myeloma, Jon reflects on the emotional, clinical, and existential uncertainties that shape living with cancer. The discussion moves beyond the patient experience to explore how uncertainty permeates everyday life, as well as oncology practice, including waiting for new therapies to become available, navigating logistical (and insurance) barriers, and interpreting evolving clinical trial data where the answers are not always clear.


    Jon is graciously donating a portion of the proceeds of the book to multiple myeloma research, so everyone who picks up a copy is donating to a good cause!

    https://www.penguinrandomhouse.com/books/760582/an-exercise-in-uncertainty-by-jonathan-gluck/

    続きを読む 一部表示
    46 分
  • ASH Leukemia Review: the more we learn, the less we know!
    2025/12/17

    In this episode, Anthony and Bernie are joined by special guest, Dr. Justin Kaner from Weill Cornell Medicine, to discuss some of the most interesting ASH abstracts in leukemia in 2025! What abstracts should change practice? Listen to find out.


    Some of the abstracts discussed:

    • PARADIGM: https://meetings-api.hematology.org/api/abstract/vmpreview/296881
    • KMT2A Outcomes (MARROW Consortium and Othman, et al.): https://meetings-api.hematology.org/api/abstract/vmpreview/302582 and https://meetings-api.hematology.org/api/abstract/vmpreview/297333
    • CLIA +/- Ven: https://meetings-api.hematology.org/api/abstract/vmpreview/302047
    • FLT3i studies (and MRD): https://meetings-api.hematology.org/api/abstract/vmpreview/295719 and https://meetings-api.hematology.org/api/abstract/vmpreview/302699 and https://meetings-api.hematology.org/api/abstract/vmpreview/291322
    • ALL GIMEMA Trial (blin + ponatinib): https://meetings-api.hematology.org/api/abstract/vmpreview/296532
    • Menin inhibitor data


    続きを読む 一部表示
    1 時間 23 分
  • RIP 7+3 (1973-2025)? Why PARADIGM Doesn't Deliver the Eulogy
    2025/12/09

    Anthony and Bernie discuss the PARADIGM study that was presented at the plenary session of ASH 2025 and whether results should change our practice.

    https://meetings-api.hematology.org/api/abstract/vmpreview/296881

    続きを読む 一部表示
    41 分
まだレビューはありません